PubMed · 2012 · 59 citations · 8 references
MedicinePharmacologyPharmacotherapyGastrointestinal PharmacotherapyNeuropharmacologyPharmacodynamicsAntiemetic PharmacologyAntiemetic TherapyDopaminergic PharmacologyNausea ManagementVomiting ControlVomiting Management5-Hydroxytryptamine 3 Receptor AntagonistsDopamine Receptor SubtypesIntractable Vomiting
Intractable nausea and/or vomiting is a serious and significant clinical dilemma that may greatly detract from quality of life. One of the first classes of antiemetic agents used as well as one of the commonest classes of antiemetic agents used is that of the dopamine receptor antagonists. Dopamine receptor antagonists are useful antiemetic agents, however, unfortunately, clinicians have on occasion resorted to switching from one dopamine receptor antagonist to another dopamine receptor antagonist when the initial dopamine receptor antagonist was ineffective rather than adding on a second antiemetic agent from a totally different class (e.g., 5-HT3 receptor antagonists, NK-1 receptor antagonists).
8
Richard J. Gralla, Loretta M. Itri, Sharon E. Pisko et al. · New England Journal of Medicine · 1981 · 710 citations
Droperidol Causes a Dose-dependent Prolongation of the QT Interval
V. Lischke, M. Behne, Peter Doelken et al. · Anesthesia & Analgesia · 1994 · 164 citations
H. Quaynor, Johan Ræder · Acta Anaesthesiologica Scandinavica · 2002 · 43 citations · Full text
Medicine, Pharmacotherapy, Surgery +15